Retatrutide is an investigational triple-hormone agonist generating major interest for weight loss. Here's an honest, physician's overview from RegenTherapy MD.
Quick answer: Retatrutide is an investigational injectable that targets three hormone pathways (GLP-1, GIP, and glucagon) and has shown striking weight-loss results in trials. It is NOT yet FDA-approved — it's still in clinical development — so it isn't something a clinic can legitimately prescribe today. A physician can tell you what's real and what's hype.
What Retatrutide is
Retatrutide is a 'triple agonist' — it acts on GLP-1 and GIP (like tirzepatide) plus a third pathway, glucagon. Early trial data has shown some of the largest average weight-loss figures seen in this drug class.
FDA & legal status (the honest version)
Retatrutide is investigational and not FDA-approved — it is still in clinical trials. That means no clinic can legitimately prescribe or sell it for weight loss right now. Anyone offering 'retatrutide' today is a red flag. RegenTherapy MD will give you an honest read on the science and get you started on an approved option (semaglutide or tirzepatide) that works now.
What it's studied for
- Weight loss via three hormone pathways
- Appetite and metabolic regulation
- Blood-sugar control (investigational)
How a physician-directed program works
At RegenTherapy MD the path is: consultation, baseline labs where indicated, a personalized plan, and monitored follow-up — all directed by Dr. Hootan Zandifar. We do not provide do-it-yourself dosing or self-injection instructions.
Who it may be right for
People following GLP-1 developments who want honest guidance and a medically supervised, approved program they can start today.
Safety & oversight
Because it's not approved, the safe and legal path now is a physician-directed program using an FDA-approved GLP-1. We'll track retatrutide's progress and advise when/if it becomes available.
Related: Semaglutide vs. Tirzepatide · Weight-loss programs.
Frequently asked questions
Can I get retatrutide now?
No — it's investigational and not FDA-approved. Approved options like semaglutide and tirzepatide are available now.
Is retatrutide better than tirzepatide?
Trial data is promising, but it isn't approved, so comparisons are premature for real-world use.
When will it be available?
It's still in clinical development; timing is uncertain. We'll advise you as it progresses.
What should I do in the meantime?
Start a medically supervised program with an approved GLP-1 — a consultation sets it up.
Book a physician consultation
Every RegenTherapy MD program is directed by Dr. Hootan Zandifar and personalized to your labs, history, and goals — never a template. Request a consultation in Beverly Hills or Santa Monica.
This page is for general education and is not medical advice. All therapies are physician-directed and require an individual consultation, medical history, and appropriate lab work. Some peptides discussed are not FDA-approved; a physician will review current status, sourcing, and suitability with you. Individual results vary.
.svg)
